The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma
- PMID: 27374456
- DOI: 10.1016/j.jtho.2016.06.014
The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma
Abstract
Introduction: Since the new adenocarcinoma (ADC) classification was presented in 2011, several authors have reported that patients with solid (S) and/or micropapillary (MP) predominant patterns showed a worse prognosis. On the other hand, there are several patients who have S and/or MP patterns even if their patterns are not predominant. However, the evaluation of these patients is uncertain.
Methods: A total of 531 ADCs were examined. We classified the patients into five subgroups according to the proportion of S and/or MP patterns: (1) both patterns absent (S-/MP-), (2) S predominant (S pre), (3) MP predominant (MP pre), (4) S pattern present although not predominant and MP pattern absent (S+ not pre/MP-), and (5) MP pattern present although not predominant (MP+ not pre).
Results: Of the 531 ADCs, 384 (72.3%) were classified as S-/MP-, 55 (10.4%) as S pre, 11 (2.1%) as MP pre, 42 (7.9%) as S+ not pre/MP-, and 39 (7.3%) as MP+ not pre. In a univariate analysis, the recurrence-free survival (RFS) and overall survival differed significantly among the five subgroups (p < 0.01 and p < 0.01, respectively). In a multivariate analysis, patients with S-/MP- had significantly higher RFS rates than did those with other subgroups. On the other hand, patients with MP pre had lower RFS rates than did those with other subgroups.
Conclusion: Patients with S and/or MP patterns have a poorer prognosis even if their patterns are not predominant. The S and/or MP patterns must be treated at the time of diagnosis.
Keywords: Lung adenocarcinoma; Micropapillary pattern; Prognosis; Solid pattern.
Copyright © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
Comment in
-
The Clinical Implications and Thoughts on Different Patterns in Resected Lung Adenocarcinoma.J Thorac Oncol. 2017 Mar;12(3):e24-e25. doi: 10.1016/j.jtho.2016.12.008. J Thorac Oncol. 2017. PMID: 28215725 No abstract available.
-
The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma: Author's Reply.J Thorac Oncol. 2017 Mar;12(3):e25-e26. doi: 10.1016/j.jtho.2016.12.020. J Thorac Oncol. 2017. PMID: 28215726 No abstract available.
-
Prognostic contribution of non-predominant solid and micropapillary components in lung adenocarcinomas.J Thorac Dis. 2017 Mar;9(3):504-506. doi: 10.21037/jtd.2017.03.15. J Thorac Dis. 2017. PMID: 28449456 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
